We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

QIAGEN

Qiagen is a provider of sample and assay technologies for molecular diagnostics and applied testing, including comple... read more Featured Products: More products

Download Mobile App





QIAGEN Demonstrates Its Revolutionary Molecular Diagnostic Solution at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 08 Feb 2023
Print article
Image: QIAGEN is participating in Medlab Middle East 2023 (Photo courtesy of QIAGEN)
Image: QIAGEN is participating in Medlab Middle East 2023 (Photo courtesy of QIAGEN)

QIAGEN N.V. (Venlo, Netherlands) is demonstrating its revolutionary NeuMoDx molecular systems at the 22nd edition of Medlab Middle East Congress taking place live, in-person from 6-9 February 2023.

The NeuMoDx molecular systems provide the industry’s first true continuous random-access solution and are scalable to meet the needs of the modern clinical laboratory. The NeuMoDx 96 and NeuMoDx 288 Molecular Systems are fully automated analyzers that use proprietary NeuDry technology, magnetic particle affinity capture, and real-time PCR chemistry in a multi-sample microfluidic cartridge. This unique integration of robotics with advanced microfluidics delivers industry-leading usability, enhanced performance, increased efficiency, and rapid turnaround.

QIAGEN is also highlighting its QIAstat-Dx multiplex syndromic testing solution that simplifies infectious disease diagnostics to help healthcare professions generate faster results for their patients. All that is needed are a patient sample, a QIAstat-Dx assay cartridge and the intuitive QIAstat-Dx instrument. QIAGEN is providing a glimpse of its upcoming QIAstat-Dx Rise, its higher capacity syndromic testing platform that will offer comprehensive pathogen coverage using the same trusted technology as the QIAstat-Dx Analyzer, tailored for high demand institutions.

Also featuring at the show is the innovative Rotor-Gene Q MDx instrument that enables high-precision real-time PCR. In combination with QIAGEN CE-IVD-marked PCR kits, the Rotor-Gene Q MDx instrument is highly suited for in vitro diagnostic applications. QIAGEN is showcasing the QIAcube Connect MDx that brings automated IVD sample processing for DNA/RNA purification within the reach of laboratories alongside the QIAsymphony SP/AS System that purifies DNA, RNA and bacterial and viral nucleic acids from a wide range of starting materials.

Among its solutions for quick and efficient routine as well as pandemic testing, QIAGEN is presenting the PAXgene Blood ccfDNA Tubes (CE-IVD) that simplify the collection and processing of whole blood for subsequent purification of circulating, cell-free DNA (ccfDNA) from plasma and genomic DNA (gDNA) from the nucleated cellular fraction. Using PAXgene Blood ccfDNA Tubes (CE-IVD) for whole blood collection, storage and transport helps prevent the release of intracellular DNA into plasma. QIAGEN is also demonstrating the PAXgene Saliva Collector which is a non-invasive sample collection device for human saliva collection, stabilization, transport and storage. Designed to simplify at-home collection without the intervention of lab personnel, the collection device contains a stabilizing solution which maintains the DNA levels in human saliva samples by protecting DNA from degradation and inhibiting bacterial growth over storage time. Additionally, QIAGEN is showcasing the QuantiFERON-TB Gold (QFT) blood test that aids in the detection of Mycobacterium tuberculosis, the bacteria which causes tuberculosis (TB).

Related Links:
QIAGEN N.V. 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.